TBP — Tetra Bio Pharma Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Brief: Tetra Bio-Pharma Announces Results Of Artificial Intelligence Study Of ARDS-003 Combined With Favipiravir
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra And Prepaire Jointly Apply To Barda For Funding
Brief: Tetra Bio-Pharma Inc Announces Revised Terms And First Closing Of Financing With Alpha Blue Ocean
Brief: Tetra Collaborates With Cellvera To Develop A Potential Oral Combination Treatment For Covid-19 Patients
Brief: Tetra Bio-Pharma announces positive preclinical results of ARDS-003, used for sepsis and viral infections
Akanda's U.S.-listed shares jump on cannabis supply pact
Brief: Akanda To Supply Tetra Bio-Pharma With Pharmaceutical-Grade Cannabis For FDA Trials Of Qixleef, A Potential Multimillion Dollar Prescription Drug
Brief: Tetra Bio-Pharma Opens New Subsidiary In Australia
Brief: Tetra Bio-Pharma Appoints Chief Financial Officer
Brief: Tetra Bio-Pharma Receives EMA Orphan Drug Designation For A Novel Topical Therapeutic Containing Cbd
Brief: Tetra Bio-Pharma Announces Licensing Agreement With True North For Patented CBD Technology
Brief: Tetra Bio-Pharma And Cannvalate Enter Into Partnership
Brief: Tetra Bio-Pharma's Qixleef On Track After Type C Meeting With U.S. FDA
Brief: Tetra Bio-Pharma Provides Update On Research Collaboration With The University Of Montreal Hospital Research Centre For Inhaled CBD
Brief: Tetra Bio-Pharma Signs License Agreement With Thorne For A Prebiotic Dietary Supplement
Brief: Tetra Bio Pharma Inc Announces Approval Of $4.5M CDN Participative Loan From Ministère De L'économie Et De L'innovation
Brief: Avicanna Enters Into A Strategic Partnership With Tetra Bio-Pharma